Tuberculosis during the COVID19 pandemic: why we can't afford to forget the world's biggest infectious disease killer
On October 21st, the next event of the LSHTM-Charité Global Health Lecture Series will take place focusing on the topic of "Tuberculosis during the COVID19 pandemic: why we can't afford to forget the world's biggest infectious disease killer".
The webinar will provide an overview of the world's largest infectious disease killer - tuberculosis- exploring the impacts of the COVID19 pandemic on access to TB services, diagnosis of TB, development of a TB vaccine and multidrug-resistant TB.
Questions guiding the event will include: What impact has COVID19 had on the diagnosis and treatment of TB? How will the pandemic affect the rise and spread of multi-drug resistant TB? What is being done to develop a vaccine to prevent TB? What opportunities and threats does COVID19 present for the prevention and treatment of TB?
Dr Katharina Kranzer, Associate Professor of Infectious Disease Epidemiology at LSHTM, Prof Stefan H. E. Kaufmann, Emeritus Director at the Max Planck Institutes for Infection Biology and for Biophysical Chemistry, and Dr Uzma Khan, Director Interactive Research and Development (IRD) will speak at the event, providing insights into the impacts of the current pandemic on tuberculosis, exploring how access to TB services, TB diagnosis, vaccine development and MDR-TB are being affected.
Prof Peter Godfrey-Faussett, Senior Science Adviser at UNAIDS and Professor of International Health and Infectious Diseases at LSHTM, will chair the event and will provide reflections on the policy context for tuberculosis in the current climate.
For more information, please refer to the flyer attached.
On the LSHTM- Charité Global Health Lecture Series:
The lecture series brings together leading scientists from the UK, Germany and further countries to present cutting-edge research on pressing global health issues and to discuss the implications of their work for policy and practice.